Your browser doesn't support javascript.
loading
Routine outcome measurement in specialist non-government alcohol and other drug treatment services: Establishing effectiveness indicators for the NADAbase.
Kelly, Peter J; Deane, Frank P; Davis, Esther L; Hudson, Suzie; Robinson, Laura D; Keane, Carol A; Hatton, Emma L; Larance, Briony.
Afiliação
  • Kelly PJ; School of Psychology, University of Wollongong, Wollongong, Australia.
  • Deane FP; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Davis EL; School of Psychology, University of Wollongong, Wollongong, Australia.
  • Hudson S; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Robinson LD; School of Psychology, University of Wollongong, Wollongong, Australia.
  • Keane CA; Illawarra Health and Medical Research Institute, Wollongong, Australia.
  • Hatton EL; Network of Alcohol and other Drug Agencies, Sydney, Australia.
  • Larance B; School of Psychology, University of Wollongong, Wollongong, Australia.
Drug Alcohol Rev ; 40(4): 540-552, 2021 05.
Article em En | MEDLINE | ID: mdl-33155315
ABSTRACT
INTRODUCTION AND

AIMS:

The collection of routine outcome measurement (ROM) data provides an opportunity for service providers to conduct benchmarking to inform quality assurance practices. To conduct comparative benchmarking, it is important that services have access to comparative data. This paper aims to establish effectiveness indicators for ROM data collected within the alcohol and other drug (AOD) sector. DESIGN AND

METHODS:

ROM data were collected by specialist non-government AOD treatment services within the Network of Alcohol and other Drugs Agencies online database (i.e. NADAbase). All participants were attending treatment within New South Wales, Australia (N = 21 572). Effectiveness indicators were calculated by using effect sizes, standard error of measurement, and rates of reliable and clinically significant change. The study focused on quality of life (EUROHIS Quality of Life Scale), psychological distress (Kessler-10) and substance dependence (Substance Dependence Scale).

RESULTS:

Since 2010, 21 572 unique people have completed at least one NADAbase Client Outcome Measure. Amphetamines (36%) and alcohol (32%) were the most commonly reported primary substances of concern. Effectiveness indicators were established for the total sample, as well as for people attending residential rehabilitation (n = 8161) and community-based (n = 10 306) treatment services. Standard error of measurement was the least stringent effectiveness indicator (i.e. a higher proportion of people demonstrated improvement), while the clinically significant change was the most stringent approach. DISCUSSION AND

CONCLUSIONS:

The study demonstrated the utility of the NADAbase to establish effectiveness indicators for benchmarking purposes. Recommendations are provided for the use of benchmarking to inform quality assurance activities in the sector.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Evaluation_studies / Guideline Aspecto: Patient_preference Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Drug Alcohol Rev Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 8_ODS3_consumo_sustancias_psicoactivas Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Transtornos Relacionados ao Uso de Substâncias Tipo de estudo: Evaluation_studies / Guideline Aspecto: Patient_preference Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Drug Alcohol Rev Ano de publicação: 2021 Tipo de documento: Article